Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Apr, 2017 | Pages:
135 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
This report studies the Antibody Drug Conjugate market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Antibody Drug Conjugate market by product type and applications/end industries. The global Antibody Drug Conjugate market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Antibody Drug Conjugate. United States plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX. Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Antibody Drug Conjugate in these regions, from 2012 to 2022 (forecast), covering United States North America Europe Asia-Pacific South America Middle East and Africa The major players in global and United States Antibody Drug Conjugate market, including ImmunoGen, Seattle Genetics, Immunomedics, Pfizer, Roche / Genentech, Celldex Therapeutics, Millennium Pharmaceuticals, AbbVie, Bayer HealthCare, Astellas Pharma/Agensys, Progenics Pharmaceuticals, Mersana Therapeutics, Synthon, Heidelberg Pharma, Oxford BioTherapeutics The On the basis of product, the Antibody Drug Conjugate market is primarily split into Adcetris Kadcyl Others On the basis on the end users/applications, this report covers Multiple Myeloma Solid Tumours Bladder Cancer Kidney Cancer Ovarian Cancer Breast Cancer Glioblastoma Lung Cancer Colorectal Cancer Prostate Cancer
Table of Contents 2017-2022 Antibody Drug Conjugate Report on Global and United States Market, Status and Forecast, by Players, Types and Applications 1 Methodology and Data Source 1.1 Methodology/Research Approach 1.1.1 Research Programs/Design 1.1.2 Market Size Estimation 1.1.3 Market Breakdown and Data Triangulation 1.2 Data Source 2.1.1 Secondary Sources 2.1.2 Primary Sources 1.3 Disclaimer 2 Antibody Drug Conjugate Market Overview 2.1 Antibody Drug Conjugate Product Overview 2.2 Antibody Drug Conjugate Market Segment by Type 2.2.1 Adcetris 2.2.2 Kadcyl 2.2.3 Others 2.3 Global Antibody Drug Conjugate Product Segment by Type 2.3.1 Global Antibody Drug Conjugate Sales (Ton) and Growth (%) by Types (2012, 2016 and 2022) 2.3.2 Global Antibody Drug Conjugate Sales (Ton) and Market Share (%) by Types (2012-2017) 2.3.3 Global Antibody Drug Conjugate Revenue (Million USD) and Market Share (%) by Types (2012-2017) 2.3.4 Global Antibody Drug Conjugate Price (USD/Kg) by Type (2012-2017) 2.4 United States Antibody Drug Conjugate Product Segment by Type 2.4.1 United States Antibody Drug Conjugate Sales (Ton) and Growth by Types (2012, 2016 and 2022) 2.4.2 United States Antibody Drug Conjugate Sales (Ton) and Market Share by Types (2012-2017) 2.4.3 United States Antibody Drug Conjugate Revenue (Million USD) and Market Share by Types (2012-2017) 2.4.4 United States Antibody Drug Conjugate Price (USD/Kg) by Type (2012-2017) 3 Antibody Drug Conjugate Application/End Users 3.1 Antibody Drug Conjugate Segment by Application/End Users 3.1.1 Multiple Myeloma 3.1.2 Solid Tumours 3.1.3 Bladder Cancer 3.1.4 Kidney Cancer 3.1.5 Ovarian Cancer 3.1.6 Breast Cancer 3.1.7 Glioblastoma 3.1.8 Lung Cancer 3.1.9 Colorectal Cancer 3.1.10 Prostate Cancer 3.2 Global Antibody Drug Conjugate Product Segment by Application 3.2.1 Global Antibody Drug Conjugate Sales (Ton) and CGAR (%) by Applications (2012, 2016 and 2022) 3.2.2 Global Antibody Drug Conjugate Sales (Ton) and Market Share (%) by Applications (2012-2017) 3.3 United States Antibody Drug Conjugate Product Segment by Application 3.3.1 United States Antibody Drug Conjugate Sales (Ton) and CGAR (%) by Applications (2012, 2016 and 2022) 3.3.2 United States Antibody Drug Conjugate Sales (Ton) and Market Share (%) by Applications (2012-2017) 4 Antibody Drug Conjugate Market Status and Outlook by Regions 4.1 Global Market Status and Outlook by Regions 4.1.1 Global Antibody Drug Conjugate Market Size and CAGR by Regions (2012, 2016 and 2022) 4.1.2 North America 4.1.3 Asia-Pacific 4.1.4 Europe 4.1.5 South America 4.1.6 Middle East and Africa 4.1.7 United States 4.2 Global Antibody Drug Conjugate Sales and Revenue by Regions 4.2.1 Global Antibody Drug Conjugate Sales (Ton) and Market Share (%) by Regions (2012-2017) 4.2.2 Global Antibody Drug Conjugate Revenue (Million USD) and Market Share (%) by Regions (2012-2017) 4.2.3 Global Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) 4.2.4 North America Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) 4.2.5 Europe Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) 4.2.6 Asia-Pacific Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) 4.2.7 South America Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017) 4.2.8 Middle East and Africa Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) 4.2.9 United States Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017) 5 Global Antibody Drug Conjugate Market Competition by Players/Manufacturers 5.1 Global Antibody Drug Conjugate Sales (Ton) and Market Share by Players (2012-2017) 5.2 Global Antibody Drug Conjugate Revenue (Million USD) and Share by Players (2012-2017) 5.3 Global Antibody Drug Conjugate Average Price (USD/Kg) by Players (2012-2017) 5.4 Players Antibody Drug Conjugate Manufacturing Base Distribution, Sales Area, Product Types 5.5 Antibody Drug Conjugate Market Competitive Situation and Trends 5.5.1 Antibody Drug Conjugate Market Concentration Rate 5.5.2 Global Antibody Drug Conjugate Market Share (%) of Top 3 and Top 5 Players 5.5.3 Mergers & Acquisitions, Expansion 6 United States Antibody Drug Conjugate Market Competition by Players/Manufacturers 6.1 United States Antibody Drug Conjugate Sales (Ton) and Market Share by Players (2012-2017) 6.2 United States Antibody Drug Conjugate Revenue (Million USD) and Share by Players (2012-2017) 6.3 United States Antibody Drug Conjugate Average Price (USD/Kg) by Players (2012-2017) 6.4 United States Antibody Drug Conjugate Market Share (%) of Top 3 and Top 5 Players 7 Antibody Drug Conjugate Players/Manufacturers Profiles and Sales Data 7.1 ImmunoGen 7.1.1 Company Basic Information, Manufacturing Base and Competitors 7.1.2 Antibody Drug Conjugate Product Category, Application and Specification 7.1.2.1 Product A 7.1.2.2 Product B 7.1.3 ImmunoGen Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) 7.1.4 Main Business/Business Overview 7.2 Seattle Genetics 7.2.1 Company Basic Information, Manufacturing Base and Competitors 7.2.2 Antibody Drug Conjugate Product Category, Application and Specification 7.2.2.1 Product A 7.2.2.2 Product B 7.2.3 Seattle Genetics Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) 7.2.4 Main Business/Business Overview 7.3 Immunomedics 7.3.1 Company Basic Information, Manufacturing Base and Competitors 7.3.2 Antibody Drug Conjugate Product Category, Application and Specification 7.3.2.1 Product A 7.3.2.2 Product B 7.3.3 Immunomedics Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) 7.3.4 Main Business/Business Overview 7.4 Pfizer 7.4.1 Company Basic Information, Manufacturing Base and Competitors 7.4.2 Antibody Drug Conjugate Product Category, Application and Specification 7.4.2.1 Product A 7.4.2.2 Product B 7.4.3 Pfizer Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) 7.4.4 Main Business/Business Overview 7.5 Roche / Genentech 7.5.1 Company Basic Information, Manufacturing Base and Competitors 7.5.2 Antibody Drug Conjugate Product Category, Application and Specification 7.5.2.1 Product A 7.5.2.2 Product B 7.5.3 Roche / Genentech Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) 7.5.4 Main Business/Business Overview 7.6 Celldex Therapeutics 7.6.1 Company Basic Information, Manufacturing Base and Competitors 7.6.2 Antibody Drug Conjugate Product Category, Application and Specification 7.6.2.1 Product A 7.6.2.2 Product B 7.6.3 Celldex Therapeutics Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) 7.6.4 Main Business/Business Overview 7.7 Millennium Pharmaceuticals 7.7.1 Company Basic Information, Manufacturing Base and Competitors 7.7.2 Antibody Drug Conjugate Product Category, Application and Specification 7.7.2.1 Product A 7.7.2.2 Product B 7.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) 7.7.4 Main Business/Business Overview 7.8 AbbVie 7.8.1 Company Basic Information, Manufacturing Base and Competitors 7.8.2 Antibody Drug Conjugate Product Category, Application and Specification 7.8.2.1 Product A 7.8.2.2 Product B 7.8.3 AbbVie Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) 7.8.4 Main Business/Business Overview 7.9 Bayer HealthCare 7.9.1 Company Basic Information, Manufacturing Base and Competitors 7.9.2 Antibody Drug Conjugate Product Category, Application and Specification 7.9.2.1 Product A 7.9.2.2 Product B 7.9.3 Bayer HealthCare Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) 7.9.4 Main Business/Business Overview 7.10 Astellas Pharma/Agensys 7.10.1 Company Basic Information, Manufacturing Base and Competitors 7.10.2 Antibody Drug Conjugate Product Category, Application and Specification 7.10.2.1 Product A 7.10.2.2 Product B 7.10.3 Astellas Pharma/Agensys Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) 7.10.4 Main Business/Business Overview 7.11 Progenics Pharmaceuticals 7.12 Mersana Therapeutics 7.13 Synthon 7.14 Heidelberg Pharma 7.15 Oxford BioTherapeutics 8 Antibody Drug Conjugate Manufacturing Cost, Industrial Chain and Downstream Buyers 8.1 Antibody Drug Conjugate Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Price Trend of Key Raw Materials 8.1.3 Key Suppliers of Raw Materials 8.1.4 Market Concentration Rate of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.3 Antibody Drug Conjugate Industrial Chain Analysis 8.4 Downstream Buyers in United States 9 Marketing Strategy Analysis, Distributors and Market Effect Factors 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Distributors in Untied States 9.3 Market Effect Factors Analysis 9.3.1 Economic/Political Environmental Change 9.3.2 Downstream Demand Change 9.3.3 Technology Progress in Related Industry 9.3.4 Substitutes Threat 10 Global Antibody Drug Conjugate Market Forecast 10.1 Global Antibody Drug Conjugate Sales, Revenue Forecast (2017-2022) 10.1.1 Global Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022) 10.1.2 Global Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022) 10.2 United States Antibody Drug Conjugate Market Forecast 10.1.1 United States Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022) 10.2.2 United States Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022) 10.3 Global Antibody Drug Conjugate Forecast by Regions 10.3.1 North America Antibody Drug Conjugate Sales (Ton) and Revenue (Million USD) Forecast (2017-2022) 10.3.2 Europe Antibody Drug Conjugate Sales (Ton) and Revenue (Million USD) Forecast (2017-2022) 10.3.3 Asia-Pacific Antibody Drug Conjugate Sales (Ton) and Revenue (Million USD) Forecast (2017-2022) 10.3.4 South America Antibody Drug Conjugate Sales (Ton) and Revenue (Million USD) Forecast (2017-2022) 10.3.5 Middle East and Africa Antibody Drug Conjugate Sales (Ton) and Revenue (Million USD) Forecast (2017-2022) 10.4 Antibody Drug Conjugate Forecast by Type 10.4.1 Global Antibody Drug Conjugate Sales (Ton) and Revenue (Million USD) Forecast by Type (2017-2022) 10.4.2 United States Antibody Drug Conjugate Sales (Ton) and Revenue (Million USD) Forecast by Type (2017-2022) 10.5 Antibody Drug Conjugate Forecast by Application 10.5.1 Global Antibody Drug Conjugate Sales (Ton) Forecast by Application (2017-2022) 10.5.2 United States Antibody Drug Conjugate Sales (Ton) Forecast by Application (2017-2022) 11 Research Findings and Conclusion
List of Tables and Figures Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources Figure Antibody Drug Conjugate Product Picture Figure Global Antibody Drug Conjugate Revenue (Million USD) Status and Outlook (2012-2022) Figure United States Antibody Drug Conjugate Revenue (Million USD) Status and Outlook (2012-2022) Figure Product Picture of Adcetris Table Major Players of Adcetris Figure Global Adcetris Sales (Ton) and Growth Rate (%) (2012-2017) Figure Product Picture of Kadcyl Table Major Players of Kadcyl Figure Global Kadcyl Sales (Ton) and Growth Rate (%) (2012-2017) Figure Product Picture of Others Table Major Players of Others Figure Global Others Sales (Ton) and Growth Rate (%) (2012-2017) Table Global Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Comparison by Types (2012, 2016 and 2022) Table Global Antibody Drug Conjugate Sales (Ton) by Types (2012-2017) Table Global Antibody Drug Conjugate Sales Share (%) by Types (2012-2017) Figure Global Sales Antibody Drug Conjugate Market Share (%) by Types (2012-2017) Figure Global Sales Antibody Drug Conjugate Market Share (%) by Types in 2016 Table Global Antibody Drug Conjugate Revenue (Million USD) by Types (2012-2017) Table Global Antibody Drug Conjugate Revenue Share (%) by Types (2012-2017) Figure Global Antibody Drug Conjugate Revenue Share (%) by Types (2012-2017) Figure 2016 Global Antibody Drug Conjugate Revenue Market Share (%) by Types Table Global Antibody Drug Conjugate Price (USD/Kg) by Types (2012-2017) Table United States Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Comparison by Types (2012, 2016 and 2022) Table United States Antibody Drug Conjugate Sales (Ton) by Types (2012-2017) Table United States Antibody Drug Conjugate Sales Share (%) by Types (2012-2017) Figure United States Sales Antibody Drug Conjugate Market Share (%) by Types (2012-2017) Figure United States Sales Antibody Drug Conjugate Market Share (%) by Types in 2016 Table United States Antibody Drug Conjugate Revenue (Million USD) by Types (2012-2017) Table United States Antibody Drug Conjugate Revenue Share (%) by Types (2012-2017) Figure United States Antibody Drug Conjugate Revenue Share (%)by Types (2012-2017) Figure 2016 United States Antibody Drug Conjugate Revenue Market Share (%) by Types Table United States Antibody Drug Conjugate Price (USD/Kg) by Types (2012-2017) Figure Multiple Myeloma Examples Figure Solid Tumours Examples Figure Bladder Cancer Examples Figure Kidney Cancer Examples Figure Ovarian Cancer Examples Table United States Antibody Drug Conjugate Sales (Ton) Comparison by Applications (2012-2022) Table Global Antibody Drug Conjugate Sales (Ton) by Applications (2012-2017) Table Global Antibody Drug Conjugate Sales Share (%) by Applications (2012-2017) Figure Global Sales Antibody Drug Conjugate Market Share (%) by Applications (2012-2017) Figure Global Sales Antibody Drug Conjugate Market Share (%) by Applications in 2016 Table United States Antibody Drug Conjugate Sales (Ton) Comparison by Applications (2012-2022) Table United States Antibody Drug Conjugate Sales (Ton) by Applications (2012-2017) Table United States Antibody Drug Conjugate Sales Share (%) by Applications (2012-2017) Figure United States Sales Antibody Drug Conjugate Market Share (%) by Applications (2012-2017) Figure United States Sales Antibody Drug Conjugate Market Share (%) by Applications in 2016 Table Global Antibody Drug Conjugate Revenue (Million USD) and CAGR Comparison by Regions (2012-2022) Figure North America Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) (2012-2022) Figure Asia-Pacific Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) (2012-2022) Figure Europe Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) (2012-2022) Figure South America Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) (2012-2022) Figure Middle East and Africa Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) (2012-2022) Figure United States Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) (2012-2022) Table Global Antibody Drug Conjugate Sales (Ton) by Regions (2012-2017) Figure Global Antibody Drug Conjugate Sales Market Share (%) by Regions (2012-2017) Figure Global Antibody Drug Conjugate Sales Market Share (%) by Regions (2012-2017) Figure 2016 Global Antibody Drug Conjugate Sales Market Share (%) by Regions Figure 2016 United States Antibody Drug Conjugate Sales Market Share (%) in Global Market Table Global Antibody Drug Conjugate Revenue (Million USD) by Regions (2012-2017) Table Global Antibody Drug Conjugate Revenue Market Share (%) by Regions (2012-2017) Figure Global Antibody Drug Conjugate Revenue Market Share (%) by Regions (2012-2017) Figure 2016 Global Antibody Drug Conjugate Revenue Market Share (%) by Regions Table Global Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Table North America Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Table Europe Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Table Asia-Pacific Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Table South America Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Table Middle East and Africa Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Table United States Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Table Global Antibody Drug Conjugate Sales (Ton) of Key Players (2012-2017) Table Global Antibody Drug Conjugate Sales Share (%) by Players (2012-2017) Figure 2016 Global Antibody Drug Conjugate Sales Share (%) by Players Figure 2017 Global Antibody Drug Conjugate Sales Share (%) by Players Table Global Antibody Drug Conjugate Revenue (Million USD) by Players (2012-2017) Table Global Antibody Drug Conjugate Revenue Share (%) by Players (2012-2017) Table 2016 Global Antibody Drug Conjugate Revenue Share (%) by Players Table 2016 Global Antibody Drug Conjugate Revenue Share (%) by Players Table Global Market Antibody Drug Conjugate Average Price (USD/Kg) by Players (2012-2017) Table United States Antibody Drug Conjugate Top Players Manufacturing Base Distribution and Sales Area Table United States Antibody Drug Conjugate Top Players Product Category Figure Global Antibody Drug Conjugate Market Share (%) of Top 3 Players Figure Global Antibody Drug Conjugate Market Share (%) of Top 5 Players Table United States Antibody Drug Conjugate Sales (Ton) by Players (2012-2017) Table United States Antibody Drug Conjugate Sales Market Share (%) by Players (2012-2017) Figure 2016 United States Antibody Drug Conjugate Sales Share (%) by Players Figure 2017 United States Antibody Drug Conjugate Sales Share (%) by Players Table United States Antibody Drug Conjugate Revenue (Million USD) by Players (2012-2017) Table United States Antibody Drug Conjugate Revenue Market Share (%) by Players (2012-2017) Table 2016 United States Antibody Drug Conjugate Revenue Share (%) by Players Table 2016 United States Antibody Drug Conjugate Revenue Share (%) by Players Table United States Market Antibody Drug Conjugate Average Price (USD/Kg) by Players (2012-2017) Figure United States Antibody Drug Conjugate Market Share (%) of Top 3 Players Figure United States Antibody Drug Conjugate Market Share (%) of Top 5 Players Table ImmunoGen Basic Information List Table ImmunoGen Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Figure ImmunoGen Antibody Drug Conjugate Sales Growth Rate (2012-2017) Figure ImmunoGen Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017) Figure ImmunoGen Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017) Table Seattle Genetics Basic Information List Table Seattle Genetics Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Figure Seattle Genetics Antibody Drug Conjugate Sales Growth Rate (2012-2017) Figure Seattle Genetics Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017) Figure Seattle Genetics Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017) Table Immunomedics Basic Information List Table Immunomedics Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Figure Immunomedics Antibody Drug Conjugate Sales Growth Rate (2012-2017) Figure Immunomedics Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017) Figure Immunomedics Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017) Table Pfizer Basic Information List Table Pfizer Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Figure Pfizer Antibody Drug Conjugate Sales Growth Rate (2012-2017) Figure Pfizer Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017) Figure Pfizer Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017) Table Roche / Genentech Basic Information List Table Roche / Genentech Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Figure Roche / Genentech Antibody Drug Conjugate Sales Growth Rate (2012-2017) Figure Roche / Genentech Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017) Figure Roche / Genentech Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017) Table Celldex Therapeutics Basic Information List Table Celldex Therapeutics Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Figure Celldex Therapeutics Antibody Drug Conjugate Sales Growth Rate (2012-2017) Figure Celldex Therapeutics Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017) Figure Celldex Therapeutics Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017) Table Millennium Pharmaceuticals Basic Information List Table Millennium Pharmaceuticals Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Figure Millennium Pharmaceuticals Antibody Drug Conjugate Sales Growth Rate (2012-2017) Figure Millennium Pharmaceuticals Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017) Figure Millennium Pharmaceuticals Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017) Table AbbVie Basic Information List Table AbbVie Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017) Figure AbbVie Antibody Drug Conjugate Sales Growth Rate (2012-2017) Figure AbbVie Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017) Figure AbbVie Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017) Table Bayer HealthCare Basic Information List Table Bayer HealthCare Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Figure Bayer HealthCare Antibody Drug Conjugate Sales Growth Rate (2012-2017) Figure Bayer HealthCare Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017) Figure Bayer HealthCare Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017) Table Astellas Pharma/Agensys Basic Information List Table Astellas Pharma/Agensys Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017) Figure Astellas Pharma/Agensys Antibody Drug Conjugate Sales Growth Rate (2012-2017) Figure Astellas Pharma/Agensys Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017) Figure Astellas Pharma/Agensys Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017) Table Sales Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Antibody Drug Conjugate Figure Antibody Drug Conjugate Industrial Chain Analysis Table Major Buyers of Antibody Drug Conjugate Table Distributors/Traders List Figure Global Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022) Figure Global Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022) Figure United States Antibody Drug ConjugateAntibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022) Figure United States Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022) Table Global Antibody Drug Conjugate Sales (Ton) Forecast by Regions (2017-2022) Figure Global Antibody Drug Conjugate Sales Market Share (%) Forecast by Regions (2017-2022) Figure North America Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022) Figure North America Antibody Drug Conjugate Revenue and Growth Rate (%) Forecast (2017-2022) Figure Europe Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022) Figure Europe Antibody Drug Conjugate Revenue and Growth Rate (%) Forecast (2017-2022) Figure Asia-Pacific Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022) Figure Asia-Pacific Antibody Drug Conjugate Revenue and Growth Rate (%) Forecast (2017-2022) Figure South America Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022) Figure South America Antibody Drug Conjugate Revenue and Growth Rate (%) Forecast (2017-2022) Figure Middle East and Africa Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022) Figure Middle East and Africa Antibody Drug Conjugate Revenue and Growth Rate (%) Forecast (2017-2022) Table Global Antibody Drug Conjugate Sales (Million USD) Forecast by Type (2017-2022) Figure Global Antibody Drug Conjugate Sales Market Share (%) Forecast by Type (2017-2022) Table Global Antibody Drug Conjugate Revenue (Million USD) Forecast by Type (2017-2022) Figure Global Antibody Drug Conjugate Revenue Market Share (%) Forecast by Type (2017-2022) Table United States Antibody Drug Conjugate Sales (Million USD) Forecast by Type (2017-2022) Figure United States Antibody Drug Conjugate Sales Market Share (%) Forecast by Type (2017-2022) Table United States Antibody Drug Conjugate Revenue (Million USD) Forecast by Type (2017-2022) Figure United States Antibody Drug Conjugate Revenue Market Share (%) Forecast by Type (2017-2022) Table Global Antibody Drug Conjugate Sales (Ton) Forecast by Application (2017-2022) Figure Global Antibody Drug Conjugate Sales Forecast by Application (2017-2022) Table United States Antibody Drug Conjugate Sales (Ton) Forecast by Application (2017-2022) Figure United States Antibody Drug Conjugate Sales Forecast by Application (2017-2022)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
